
Michelle Monje, MD, PhD, discusses the early efficacy of a novel GD2-directed CAR T-cell therapy for the treatment of children with diffuse midline glioma.

Your AI-Trained Oncology Knowledge Connection!


Michelle Monje, MD, PhD, is the Milan Gambhir Professor of Pediatric Neuro-Oncology and a professor by courtesy of neurosurgery, pediatrics, pathology, and psychiatry and behavioral sciences at Stanford University, as well as a member of the Institute for Stem Cell Biology and Regenerative Medicine, the Maternal & Child Health Research Institute, the Wu Tsai Neurosciences Institute, and the Stanford Cancer Institute in Palo Alto, California.

Michelle Monje, MD, PhD, discusses the early efficacy of a novel GD2-directed CAR T-cell therapy for the treatment of children with diffuse midline glioma.